He said the impact would have been more severe a year or two ago when Mylan was charging more for the devices. Shares of Mylan rose $1.46 to $36.83 in early afternoon trading on the New York Stock Exchange.
"Supply constraints" prevented adequate stock, according to the society's notice ... In response to the letter, Mylan said that the FDA warning did not "affect Pfizer's ability to manufacture and supply" products from the facility.
Mylan NV (NASDAQ:MYL) shares should be rising. Morgan Stanley upgraded Mylan stock just a few days ago, calling it the best pick among the domestic generic drugmakers. And, just this week Mylan announced it had launched an …
Mylan CEO Heather Bresch Mylan (MYL) reported Q4 revenue of $3.2 billion and EPS of $1.43. The company missed on revenue by $60 million, but beat on earnings. The stock was flat after the earnings announcement. I had the following …